Specimen Banking From Patients With Lung Cancer

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Neoplasms Lung Diseases Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Colorado Cancer Center

Aurora, Colorado, 80045, United States

Location status: Recruiting

Location contact

Adriaan VanBokhoven, PhD

PRINCIPAL_INVESTIGATOR

Brandi Kubala

CONTACT

[email protected]

303-724-1657

About this study

The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
Oral and written informed consent

Exclusion criteria

Any individual who does not give oral and written consent for participation

Treatment and study plan

Primary outcomes

Development of a comprehensive specimen banking program from patients with lung cancer for future translational research.

Time frame: 6 years

No statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.

Study contacts

Contact information is provided by the study sponsor or research team.

Brandi Kubala

CONTACT

[email protected]

303-724-1657

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

National Cancer Institute (NCI)

Registry information

Important dates

Study start: 2005
Primary completion: 2035
Study completion: 2035
First posted: Apr 26, 2012
Registry last updated: Jan 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting